Who
Clayton Stuart Rose
Director
Company insider
Files Form 4 as: Director, Bank of America; Director, Xl Group; Director, Lexicon Pharmaceuticals; Director, Mercantile Bankshares.
In numbers
- Trades disclosed
- 40
- Buys
- 1
- Sells
- 0
- Bought
- $48K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 31 Dec 2005
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —5,365.01 | filing |
| 4 May 2026filed 6 May 2026 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —5,365.01 | filing |
| 22 Apr 2025filed 24 Apr 2025 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —7,306.89 | filing |
| 24 Apr 2024filed 26 Apr 2024 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —7,045.93 | filing |
| 25 Apr 2023filed 27 Apr 2023 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —9,362 | filing |
| 26 Apr 2022filed 28 Apr 2022 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —6,858.71 at $0.00 | filing |
| 20 Apr 2021filed 22 Apr 2021 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —6,565.13 at $0.00 | filing |
| 22 Apr 2020filed 24 Apr 2020 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —11,467.89 at $0.00 | filing |
| 24 Apr 2019filed 26 Apr 2019 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —8,327.78 at $0.00 | filing |
| 24 Oct 2018filed 26 Oct 2018 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —4,759.45 at $0.00 | filing |
| 26 May 2017filed 31 May 2017 | Xl Group | SEC FORM 4 Code A | —3,465 at $0.00 | filing |
| 8 Aug 2016filed 10 Aug 2016 | Xl Group | SEC FORM 4 Code A | —3,317 at $0.00 | filing |
| 20 May 2016filed 24 May 2016 | Xl Group | SEC FORM 4 Code A | —1,089 at $0.00 | filing |
| 20 May 2016filed 24 May 2016 | Xl Group | SEC FORM 4 Code F | $4,341126 at $34.45 | filing |
| 8 May 2015filed 12 May 2015 | Xl Group | SEC FORM 4 Code A | —4,057 at $0.00 | filing |
| 8 May 2015filed 12 May 2015 | Xl Group | SEC FORM 4 Code F | $48K1,299 at $36.98 | filing |
| 7 May 2014filed 9 May 2014 | BAC Bank of Americaoption or derivative · Money-centre banks | SEC FORM 4 Code A | —10,810.81 | filing |
| 6 May 2014filed 8 May 2014 | Xl Group | SEC FORM 4 Code A | —4,716 at $0.00 | filing |
| 6 May 2014filed 8 May 2014 | Xl Group | SEC FORM 4 Code F | $48K1,509 at $31.81 | filing |
| 1 Aug 2013filed 5 Aug 2013 | BAC Bank of AmericaMoney-centre banks | SEC FORM 4 Code A | $126K8,415 at $14.95 | filing |
News
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin's Biological Effects in Cardiovascular DiseaseLXRX · manilatimes.net · 21 Oct 2026
0 headlines in the last 90 days name Clayton Stuart Rose; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.